|

Perampanel 6 MG Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • Yale University1

Indications

  • Major Depressive Disorder1
  • Suicidal Ideation1
  • Bipolar Disorder1
  • Depressive Disorder1
  • Post Traumatic Stress Disorder1

West Haven, Connecticut1 trial

The Impact of AMPA Receptor Blockade on Ketamine's Anti-Suicidal Effects

VA Connecticut Healthcare System

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.